Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trialKazumoto Iijima, Yasuo Ohashi, Koichi Kamei et al.|The Lancet|2014Cited by 450
Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximabKazumoto Iijima, Koichi Kamei, Kenji Ishikura et al.|Pediatric Nephrology|2017Cited by 54
A cross-sectional nationwide survey of congenital and infantile nephrotic syndrome in JapanYuko Hamasaki, Kazumoto Iijima, Riku Hamada et al.|BMC Nephrology|2020Cited by 6